SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Stockman Scott's Political Debate Porch -- Ignore unavailable to you. Want to Upgrade?


To: SOROS who wrote (8269)10/21/2002 3:59:31 PM
From: SOROS  Read Replies (1) | Respond to of 89467
 
I'm too old for this trading stuff. Closed it out.

I remain,

SOROS



To: SOROS who wrote (8269)10/21/2002 11:33:24 PM
From: pbull  Read Replies (2) | Respond to of 89467
 
I'm an old-timer. I remember in '74 when companies that were growing at 20%+ a year traded at 12x earnings _ or less in some cases.
You can find them again in this market. It's been a long time, silliness has reined supreme for so long, but there are real bargains out there.
And no, I don't mean F. I mean companies that are growing, not mired in some unholy quagmire.
The president's decision today on generic drugs means the big drug companies will have to spend heavily to develop new drugs. The generic drug makers will benefit, the biotechs will benefit, and, longer term, the big drug companies benefit by discovering new treatments.
Health-care is a good secular growth story, but only recently have valuations become attractive.
Tech is looking a little better, too.
As for GS, keep in mind that investment banking has been flat on its back for, well, 4 or 5 years now. Which is not to say GS is a bargain. It's just that GS and JPM and so forth already have survived a harsh climate for a good spell. The bucket shops are one thing, GS and JPM are another.
Only my opinion, and I have been known to be wrong.

PB